Navigation Links
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study
Date:8/6/2014

WORCESTER, Mass. and TORONTO, Aug. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer.  The study demonstrates an association between a specific immune response generated by AE37 and improved overall survival.  The compound is being developed by Antigen Express, Inc. (www.antigenexpress.com), a wholly-owned subsidiary of Generex, for multiple cancer indications.

The publication, entitled, "AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction," appears in the peer-reviewed journal Cancer Immunology, Immunotherapy, a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy (online publication July 23, 2014).  While a prior study showed that AE37-immunized patients had better overall and disease-free survival as a group than would be expected from their disease status, the current study shows that patients with the strongest immunological response did the best.  In particular, both the presence of AE37-induced T cells in peripheral blood as well as a robust delayed type hypersensitivity (DTH) response elicited by AE37 correlated significantly with overall survival.  The authors point out the importance of CD4+ T cells in developing a good DTH response.  AE37 was developed using the Antigen Express Ii-Key technology platform that ensures robust, specific CD4+ T cell activation.

The current report expands upon prior studies on the results of a Phase I trial of AE37 in patients with prostate cancer.  AE37 is also the subject of a controlled, randomized Phase II trial t
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
2. Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference
3. Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial
4. Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
5. Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
6. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
7. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
8. Generex Announces Date of Annual Stockholders Meeting
9. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
10. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
11. Generex Secures Commitments for $3.6M Capital Raise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... LONDON , August 3, 2015 ... Portland Hospital waved the shortfall of ... fanatic could stand normally for the first time. ...      (Photo: http://photos.prnewswire.com/prnh/20150803/254229 ) The ... Jude,s legs allowing him to carry out his wish ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Aethlon Medical, ... affinity biofiltration devices to treat life-threatening diseases, today announced ... investor conference call and webcast on Thursday, August 13, ... call and webcast will follow the release of fiscal ... call will be available approximately two hours after the ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces the ... line of analytical laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, ... resistant and maintenance-free solution for a broad range of vacuum filtration applications. , ...
(Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
Breaking Biology Technology:Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Sterlitech Launches New Line of Vacuum Pumps 2Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2
... ... Doren, PharmD, will present at the 9th DIA Conference for Contemporary Pharmacovigilance and Risk Management ... present on the topic of the Integrated Summary of Safety. , ... Emeryville, CA (PRWEB) November 18, 2009 -- BioSoteria, Inc., ...
... , ... Medical Centers Simplify Clinical Workflow Using iSirona Technology , ... Panama City, Fla. (PRWEB) November ... today announced the successful "go-live" of iSirona,s DeviceConX at University Hospitals Geneva Medical ...
... activity in the brain. Even the mere possibility of receiving ... brain called the striatum. A team of Japanese researchers report ... , published by Elsevier, the results of a study in ... task and found high-risk/high-gain options to cause higher levels of ...
Cached Biology Technology:BioSoteria CEO to Present at Drug Safety Conference 2iSirona Announces Go-live at University Hospitals in Cleveland 2iSirona Announces Go-live at University Hospitals in Cleveland 3Monetary gain and high-risk tactics stimulate activity in the brain 2
(Date:7/27/2015)... 27, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Huawei has selected the Synaptics ... its stylish smartwatch. Huawei chose the state-of-the-art ClearPad ... power and highly responsive human interface qualities such ... also required a classic round watch face and ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... Disorder , (#1119044, Wednesday, October 26, 3:00 PM Eastern) , ... vary in intensity, may be an indicator of periodic limb ... PMLD, researchers from Toledo, Ohio divided the patients into those ... 84 right-handed and 16 left-handed patients, 69% of right-handed patients ...
... PA, October 24, 2011 Nutrition Facts labels have ... these labels read in detail by consumers when making ... labels? According to a new study published in the ... Dietetic Association, consumers, self-reported viewing of Nutrition Facts ...
... for Science and Technology is the first post-secondary school to ... Experiments . Though JoVE , the first and ... video articles showing basic experimental procedures, the majority of the ... -- not the level of research one would usually associate ...
Cached Biology News:CHEST 2011: Embargoed studies highlight new sleep disorder research 2CHEST 2011: Embargoed studies highlight new sleep disorder research 3Consumers don't pay as much attention to nutrition fact labels as they think 2Consumers don't pay as much attention to nutrition fact labels as they think 3
Polyclonal Antibody to SHPRH...
Purified anti-PI3K p110 delta...
... Antigen Afinity Purified Tyrosine Hydroxylase ... antibody was raised against synthetic ... residues surrounding the phospho-Ser40 of ... antibody was purified by sequential ...
NF kappa B Related Sampler Kit 10g each...
Biology Products: